Strontium-based composition, product, and method of using the same to control progression of osteoarthritis osteoporosis and tooth decay
US9974804B1 · kind B1 · utility
Inventor
Key dates
| Filing date | Sep 8, 2017 |
| Grant date | May 22, 2018 |
| Priority date | — |
| Expiry date | Sep 8, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2800/58
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A strontium-based composition for controlling progression of osteoarthritis, osteoporosis, and tooth decay is presented. The composition may include a blend of ingredients including: at least 500 mg of strontium carbonate; citric acid; ascorbic acid; malic acid; folic acid; vitamin d3; magnesium citrate; natural sweetener; and flavoring. The all-natural strontium-based blend of ingredients is simply delivered to the oral cavity where an “in-vivo” chemical reaction takes place resulting in direct tooth and dentin exposure to facilitate direct dental anti-caries and anti-sensitivity strontium benefits. The blend of ingredients is then swallowed to establish intestinal transit and absorption to obtain the targeted benefits of systemic absorption to bone and joint areas.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.